Avlar BioVentures
Venture capitalMadingley · Series A–Growth
Frequently asked questions
- What stage does Avlar BioVentures invest at?
- Avlar BioVentures invests at the Series A, Series B, Series C, Growth stages.
- What sectors does Avlar BioVentures focus on?
- Avlar BioVentures focuses on Biotech, Healthtech, IoT, Medical Devices.
- Where is Avlar BioVentures located?
- Avlar BioVentures is headquartered in Madingley, GB.
Similar investors
Ambix invests in medical devices, biochemistry-based technologies, and digital health solutions addressing unmet healthcare needs, supporting companies from early-stage startups through later-stage commercial expansion.
M Ventures is the corporate venture arm of Merck KGaA based in Darmstadt, Germany, operating from offices in Amsterdam, the US, and Israel. The firm invests globally across early-stage companies and spin-offs in areas aligned with Merck's core business, taking active roles in portfolio company development.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
SoftBank China Capital is a venture capital and private equity fund management firm established in 2000 that invests in high-growth, high-technology enterprises across Greater China. The firm manages multiple USD and RMB funds with focus areas including information technology, medical health, new energy, and advanced intelligent manufacturing.